A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Clinical trial NCT05775575 · UNKNOWN

Trial details

NCT number: NCT05775575
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2023-03-02
Primary completion: 2023-12-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.